Medicare regulators proposed on Tuesday to ban vendors from providing remote patient monitoring services on behalf of doctors, marking a major policy shift for a rapidly growing care model that has drawn increasing scrutiny. The proposed change would reshape how remote monitoring is delivered across the Medicare program and reflects concern from federal watchdogs, academics, and insurers that current payments fund low-value services.
Remote patient monitoring allows doctors to track patients’ health data from a distance, typically using wearable devices or home-based sensors. Medicare has covered the service since 2018, and payments for remote monitoring ballooned to over $500 million in 2024. If the Centers for Medicare and Medicaid Services finalizes the proposed rule, a large percentage of remote monitoring care as it exists today would be eliminated.
The ban specifically targets vendors, third-party companies that bill Medicare on behalf of physicians for remote monitoring services. Under the proposal, doctors would no longer be able to use vendor intermediaries to deliver these services to Medicare beneficiaries. This represents a fundamental restructuring of the remote monitoring business model that has grown substantially over the past six years.
Why Medicare Is Tightening Remote Monitoring Rules
The proposal follows widespread concern that the current system pays for services that provide minimal clinical value. The Health and Human Services Office of Inspector General, along with academic researchers and private insurers, have raised alarms about whether remote monitoring truly improves patient outcomes or primarily generates billing revenue.
Payments for remote monitoring have grown faster than evidence supporting its effectiveness. The spike in spending, combined with uncertainty about clinical benefit, prompted Medicare to reconsider how it reimburses the service. The watchdog office’s scrutiny helped accelerate the regulatory review.
The proposed ban also fits within the Trump administration’s broader effort to root out fraud and wasteful spending in Medicare. Officials have made reducing improper payments and eliminating low-value care a priority as they seek to stabilize the program’s finances.
A Shift Away From Third-Party Vendors
The core of the proposal requires doctors to provide remote monitoring services directly to patients rather than outsourcing the work to vendors. This changes the operational structure of how remote monitoring functions within Medicare. Physicians would become responsible for managing patient monitoring themselves or hiring staff to do so internally.
Vendors have played a central role in remote monitoring’s growth. These companies handle patient enrollment, device management, data collection, billing, and customer service on behalf of medical practices. By removing vendors from the equation, Medicare aims to ensure that only clinically necessary monitoring occurs and that doctors, not intermediaries, control the decision to monitor patients remotely.
The shift would particularly affect smaller medical practices and independent physicians who lack the infrastructure to manage remote monitoring in-house. Large health systems with existing digital health capabilities may face less disruption, though they too would need to adjust their vendor relationships.
An Alternative Model Emerges
The Centers for Medicare and Medicaid Services has not left remote monitoring entirely unsupported. The agency recently launched an alternative model to pay for digital health services, creating a pathway for remote monitoring to continue under different payment and delivery rules. This alternative model would require doctors to meet stricter criteria and demonstrate that remote monitoring provides measurable clinical benefit.
The new model reflects Medicare’s intent to preserve remote monitoring for patients who genuinely need it while eliminating services that do not improve care. Details on how the alternative model operates remain limited, but the framework suggests Medicare will require stronger evidence of clinical value before reimbursement.
What Changes for Patients and Providers
Patients currently receiving remote monitoring through vendor-managed programs may see interruptions in service if the ban is finalized without a transition period. The proposal does not specify an implementation timeline or grace period for existing monitoring programs to shift to direct physician management.
Physicians using vendors would face two options: develop internal remote monitoring capabilities or discontinue the service for Medicare beneficiaries. The latter choice would be simpler operationally but would eliminate a revenue source for practices. The former requires investment in staff, technology, and training that not all practices can afford.
Vendors themselves face significant uncertainty. Established remote monitoring companies would lose their Medicare billing authority and would need to pivot their business models. Some may offer services to patients with private insurance, which is not subject to the same restrictions. Others may exit the market entirely.
The Road Ahead
The proposed rule is now open for public comment. Medical practices, vendors, patient advocacy groups, and insurers are likely to submit feedback before Medicare decides whether to finalize the ban. The comment period will reveal how strongly stakeholders oppose or support the shift.
If finalized, the ban would represent one of the most significant Medicare policy changes affecting digital health in recent years. It signals that federal regulators are willing to restrict access to a popular technology when evidence of clinical benefit falls short. Whether the alternative model provides a viable replacement for remote monitoring, and whether physicians can absorb the operational burden of direct management, remains to be seen.
